INTRANASAL APOMORPHINE IN PARKINSONS-DISEASE

被引：40

作者：

KLEEDORFER, B

TURJANSKI, N

RYAN, R

LEES, AJ

MILROY, C

STERN, GM

机构：

[1] MIDDLESEX HOSP,DEPT NEUROL,MORTIMER ST,LONDON W1N 8AA,ENGLAND

[2] UNIV COLL HOSP LONDON,WC1 LONDON,ENGLAND

[3] MIDDLESEX HOSP,DEPT EAR NOSE & THROAT,LONDON W1N 8AA,ENGLAND

来源：

NEUROLOGY | 1991年 / 41卷 / 05期

关键词：

D O I：

10.1212/WNL.41.5.761-a

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：761 / 762

页数：2

共 6 条

[1] A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONS-DISEASE [J].

CANTER, GJ ;

DELATORRE, R ;

MIER, M .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1961, 133 (02) :143-147

[2] INTRANASAL APOMORPHINE - A NEW TREATMENT IN PARKINSONS-DISEASE [J].

KAPOOR, R ;

TURJANSKI, N ;

FRANKEL, J ;

KLEEDORFER, B ;

LEES, A ;

STERN, G ;

BOVINGDON, M ;

WEBSTER, R .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (11) :1015-1015

[3] SUBLINGUAL APOMORPHINE AND PARKINSONS-DISEASE [J].

LEES, AJ ;

MONTASTRUC, JL ;

TURJANSKI, N ;

RASCOL, O ;

KLEEDORFER, B ;

STPAUL, HP ;

STERN, GM ;

RASCOL, A .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (12) :1440-1440

[4]

POEWE W, 1988, LANCET, V1, P943

[5]

STIBE CMH, 1988, LANCET, V1, P403

[6]

WEBSTER DD, 1968, MOD TREAT, V5, P257

← 1 →